Hex:7 HexNAc:6 dHex:4 NeuAc:2

Taxonomy

• Homo sapiens (Human)
• Severe acute respiratory syndrome coronavirus 2 (2019-nCoV)

Protein

• Folate receptor alpha / Homo sapiens    P15328
• Integrin beta-1 / Homo sapiens    P05556
• Laminin subunit gamma-1 / Homo sapiens    P11047
• Lumican / Homo sapiens    P51884
• Lysosome membrane protein 2 / Homo sapiens    Q14108
• Recombinant Spike glycoprotein (BTI-Tn-5B1-4) / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV)    P0DTC2

Source

• Blood Serum (UBERON_0001977)  
• Mammary Gland (UBERON_0001911)  
• BTI-Tn-5B1-4 (CVCL_C190)  

Reported structure

Composition

• Hex:7 HexNAc:6 dHex:4 NeuAc:2 (avg mass : 3539.2699 )

Disease

• Cancer, breast (DOID:1612)
• COVID-19 (DOID:0080600)
• Prostate cancer (DOID:10283)

Reference

• Site-specific N-glycosylation Characterization of Recombinant SARS-CoV-2 Spike Proteins using High-Resolution Mass Spectrometry (2020 - Yong Zhang, Wanjun Zhao, Yonghong Mao, Shisheng Wang, Yi Zhong, Tao Su, Meng Gong, Xiaofeng Lu, Jingqiu Cheng, Hao Yang) / Status : Unreviewed
• Reanalysis of global proteomic and phosphoproteomic data identified a large number of glycopeptides (2018 - Yingwei Hu, Punit Shah, David J. Clark, Minghui Ao, Hui Zhang) / Status : Unreviewed
• Large-scale intact glycopeptide identification by Mascot database search (2018 - Ravi Chand Bollineni, Christian Jeffrey Koehler, Randi Elin Gislefoss, Jan Haug Anonsen, Bernd Thiede) / Status : Unreviewed

Reported glycosite

• Folate receptor alpha / Homo sapiens
  •        Asn-161
• Integrin beta-1 / Homo sapiens
  •        Asn-669
• Laminin subunit gamma-1 / Homo sapiens
  •        Asn-650
• Lumican / Homo sapiens
  •        Asn-88
  •        Asn-127
  •        Asn-252
• Lysosome membrane protein 2 / Homo sapiens
  •        Asn-105
• Recombinant Spike glycoprotein (BTI-Tn-5B1-4) / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV)
  •        Asn-61
  •        Asn-74
  •        Asn-331
  •        Asn-343
  •        Asn-657
  •        Asn-709
  •        Asn-717
  •        Asn-1074
  •        Asn-1159
  •        Asn-1174
  •        Asn-1194

Mass spectrometry observed peptide

• SSVLHSTQDLFLPFFSNVTWFHAIHVSGTNGTK (33aa)
  •    P0DTC2    Asn-74
• SSVLHSTQDLFLPFFSNVTWFHAIHVSGTNGTKR (34aa)
  •    P0DTC2    Asn-61
• SSVLHSTQDLFLPFFSNVTWFHAIHVSGTNGTKR (34aa)
  •    P0DTC2    Asn-74
• AFENVTDLQWLILDHNLLENSK (22aa)
  •    P51884    Asn-88
• ANIQFGDNGTTISAVSNK (18aa)
  •    Q14108    Asn-105
• LHINHNNLTESVGPLPK (17aa)
  •    P51884    Asn-127
• KLHINHNNLTESVGPLPK (18aa)
  •    P51884    Asn-127
• GWNWTSGFNK (10aa)
  •    P15328    Asn-161
• ISHNEIADSGIPGNSFNVSSIVEIDISYNK (30aa)
  •    P51884    Asn-252
• VQPTESIVRFPNITNLCPFGEVFNATR (27aa)
  •    P0DTC2    Asn-343
• VQPTESIVRFPNITNLCPFGEVFNATR (27aa)
  •    P0DTC2    Asn-331
• FPNITNLCPFGEVFNATR (18aa)
  •    P0DTC2    Asn-331
• GIYQTSNFRVQPTESIVRFPNITNLCPFGEVFNATR (36aa)
  •    P0DTC2    Asn-331
• GIYQTSNFRVQPTESIVRFPNITNLCPFGEVFNATR (36aa)
  •    P0DTC2    Asn-343
• LLNNLTSIK (9aa)
  •    P11047    Asn-650
• AGCLIGAEHVNNSYE (15aa)
  •    P0DTC2    Asn-657
• HVNNSYE (7aa)
  •    P0DTC2    Asn-657
• AGCLIGAEHVNNSYECDIPIGAGICASYQTQTNSPR (36aa)
  •    P0DTC2    Asn-657
• KDTCTQECSYFNITK (15aa)
  •    P05556    Asn-669
• NSVAYSNNSIAIPTNFTISVTTE (23aa)
  •    P0DTC2    Asn-717
• NSVAYSNNSIAIPTNFTISVTTE (23aa)
  •    P0DTC2    Asn-709
• KNFTTAPAICHDGK (14aa)
  •    P0DTC2    Asn-1074
• EELDKYFKNHTSPDVDLGDISGINASVVNIQK (32aa)
  •    P0DTC2    Asn-1174
• ELDKYFKNHTSPDVDLGDISGINASVVNIQKE (32aa)
  •    P0DTC2    Asn-1159
• ELDKYFKNHTSPDVDLGDISGINASVVNIQKE (32aa)
  •    P0DTC2    Asn-1174
• YFKNHTSPDVDLGDISGINASVVNIQK (27aa)
  •    P0DTC2    Asn-1174
• NHTSPDVDLGDISGINASVVNIQKE (25aa)
  •    P0DTC2    Asn-1159
• NHTSPDVDLGDISGINASVVNIQK (24aa)
  •    P0DTC2    Asn-1159
• NHTSPDVDLGDISGINASVVNIQK (24aa)
  •    P0DTC2    Asn-1174
• YFKNHTSPDVDLGDISGINASVVNIQKE (28aa)
  •    P0DTC2    Asn-1159
• VAKNLNESLIDLQE (14aa)
  •    P0DTC2    Asn-1194